Literature DB >> 17374583

99Tcm-DISIDA hepatobiliary imaging in evaluating gallbladder function in patients with spinal cord injury.

Chang-Suo Xia1, Xuan-Ying Yang, Guang-Xiang Hong.   

Abstract

BACKGROUND: Spinal cord injury (SCI) is associated with increased prevalence of gallstones and acute acalculous cholecystitis. A possible explanation for the increased prevalence of gallstones in SCI patients is decreased gallbladder motility causing gallbladder stasis. In this study, we investigated gallbladder function in patients with SCI.
METHODS: Eighteen normal controls, 16 trauma controls and 46 SCI patients were included in this study. Gallbladder function was measured by technium 99m-labeled imino-diacetic acid analogue ((99)Tc(m)-DISIDA) hepatobiliary imaging and represented by filling fraction (FF) and ejection fraction (EF). The data from SCI patients were analyzed according to old versus young, female versus male, heavy versus light body weight, ASIA A & B versus ASIA C & D classification, high- versus low-level injury, and long versus short injury duration.
RESULTS: Fifty-two percent of SCI patients had abnormal FF and 59% had abnormal EF. Significantly decreased FF and EF values were found in SCI patients, especially in female patients with severe and high-level injuries.
CONCLUSION: Quantitative (99)Tc(m)-DISIDA cholescintigraphy showed that SCI can significantly impair gallbladder function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374583

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  2 in total

Review 1.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

2.  Increased risk of acute pancreatitis in persons with spinal cord injury: a population-based, propensity score-matched longitudinal follow-up study.

Authors:  Wei-Te Ho; Kuo-Cheng Yeh; Shin-Liang Pan
Journal:  Spinal Cord       Date:  2021-06-01       Impact factor: 2.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.